Your session is about to expire
← Back to Search
Other
menthol cigarettes for Nicotine Addiction
Phase < 1
Waitlist Available
Led By Mehmet Sofuoglu, M.D.,Ph.D.
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one year
Awards & highlights
Study Summary
This trial is examining if smokers who switch from menthol to non-menthol cigarettes will change the dose-effect curves for positive subjective effects and alleviation of smoking urges as a function of nicotine delivery rate.
Eligible Conditions
- Nicotine Addiction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
money choice questionaire
Secondary outcome measures
SAFTEE
Trial Design
2Treatment groups
Active Control
Group I: menthol cigarettesActive Control1 Intervention
Will smoke only menthol cigarettes for two weeks
Group II: non menthol cigarettessActive Control1 Intervention
Will only smoke non menthol cigarettes for two weeks
Find a Location
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,863 Previous Clinical Trials
2,742,563 Total Patients Enrolled
4 Trials studying Nicotine Addiction
194 Patients Enrolled for Nicotine Addiction
National Institute on Drug Abuse (NIDA)NIH
2,485 Previous Clinical Trials
2,622,362 Total Patients Enrolled
15 Trials studying Nicotine Addiction
2,130 Patients Enrolled for Nicotine Addiction
Mehmet Sofuoglu, M.D.,Ph.D.Principal Investigator - Yale University
Yale University
8 Previous Clinical Trials
235 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger